1994
DOI: 10.1016/0165-1161(94)90037-x
|View full text |Cite
|
Sign up to set email alerts
|

Recommendations for the performance of bacterial mutation assays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
68
0
3

Year Published

1999
1999
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 195 publications
(75 citation statements)
references
References 30 publications
4
68
0
3
Order By: Relevance
“…The positive controls in the absence of metabolic activator (-S9) were 2-aminofluorine (2-AF) for TA98 and TA100. Each determination was made in triplicate and at least two independent experiments were carried out to confirm the results (Gatehouse et al, 1994).…”
Section: Mutagenicity Assaymentioning
confidence: 99%
“…The positive controls in the absence of metabolic activator (-S9) were 2-aminofluorine (2-AF) for TA98 and TA100. Each determination was made in triplicate and at least two independent experiments were carried out to confirm the results (Gatehouse et al, 1994).…”
Section: Mutagenicity Assaymentioning
confidence: 99%
“…According to latest Guidance on classification of chemicals [27], the classification of individual substanc- activity [31,32]; Gatehouse, et al, 1994) [31][32][33]. It is widely accepted that positive results in the Ames test correlate well with carcinogenic potential, at least in rodents (70%-90% predictivity; [28].…”
Section: Testing For Mutagenicity Potential According To Regulatory Cmentioning
confidence: 99%
“…The mutagenic activity of these compounds were assessed by the Salmonella microsome assay (Ames test), using S. typhimurium test strains TA98, TA97a (to detect frameshift mutations), TA100 (to detect base-pair-substitution mutations) and TA102 (normally used to detect mutagens that cause oxidative damage and base-pair-substitution mutations), in the presence or absence of in vitro metabolizing systems [14]- [16]. Results of genetic toxicological tests, combined with an adequate pharmacology profile, have been used to approve clinical trials of novel drug candidates [17].…”
Section: Introductionmentioning
confidence: 99%